Cargando…

Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

The morbidity and mortality benefits of lowering blood pressure (BP) in hypertensive patients are well established, with most individuals requiring multiple agents to achieve BP control. Considering the important role of the renin-angiotensin-aldosterone system (RAAS) in the pathophysiology of hyper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nash, David T, McNamara, Michael S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172087/ https://www.ncbi.nlm.nih.gov/pubmed/21949614

Ejemplares similares

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
por: Varagic, Jasmina, et al.
Publicado: (2014)

Clinical utility of valsartan in the treatment of hypertension in children and adolescents
por: Baracco, Rossana, et al.
Publicado: (2011)

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
por: Giles, Thomas D., et al.
Publicado: (2017)

Exforge(®) (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact
por: Krzesinski, Jean-Marie, et al.
Publicado: (2010)

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
por: Mengden, Thomas, et al.
Publicado: (2009)

Current perspectives on combination therapy in the management of hypertension
por: Mallat, Samir G, et al.
Publicado: (2013)

Clinical utility of azilsartan–chlorthalidone fixed combination in the management of hypertension
por: Shuster, Jerrica E, et al.
Publicado: (2012)

Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
por: Pimenta, Eduardo, et al.
Publicado: (2008)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Clinical utility of valsartan in treatment of children and adolescents with high blood pressure
por: Kaushik, Manu, et al.
Publicado: (2011)

Overview of clinical use and side effect profile of valsartan in Chinese hypertensive patients
por: Huang, Qi-Fang, et al.
Publicado: (2013)

A Review of the Efficacy and Tolerability of Combination Amlodipine/Valsartan in Non-White Patients with Hypertension
por: Ferdinand, Keith C., et al.
Publicado: (2013)

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
por: Mende, Christian W., et al.
Publicado: (2017)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension
por: Zhang, Yaling, et al.
Publicado: (2022)

Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Amlodipine/valsartan fixed-dose combination treatment in the management of hypertension: A double-blind, randomized trial
por: Wang, Kang-Ling, et al.
Publicado: (2020)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014)

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Erratum to: Additive Beneficial Effects of Valsartan Combined with Rosuvastatin in the Treatment of Hypercholesterolemic Hypertensive Patients
por: Jang, Ji-Yong, et al.
Publicado: (2015)

Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats
por: Takai, Shinji, et al.
Publicado: (2013)

Combined treatment with valsartan and fluvastatin to delay disease progression in nonpermanent atrial fibrillation with hypertension: A clinical trial
por: Zhao, Zhiqiang, et al.
Publicado: (2020)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008)

Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combination
por: Kaplinsky, Edgardo
Publicado: (2016)

The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
por: Zhao, Cong, et al.
Publicado: (2022)

The beneficial effect of combination therapy with sulfasalazine and valsartan in the treatment of ulcerative colitis
por: Asgharzadeh, Fereshteh, et al.
Publicado: (2021)

Amlodipine and valsartan as components of a rational and effective fixed-dose combination
por: Waeber, Bernard, et al.
Publicado: (2009)

Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol
por: Lee, Vivian, et al.
Publicado: (2023)

Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/Valsartan
por: De Vecchis, Renato, et al.
Publicado: (2020)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorothiazide, among Palestinian hypertensive patients
por: Zaid, Abdel Naser, et al.
Publicado: (2016)

Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
por: Segura, Julian, et al.
Publicado: (2011)

Effectiveness of Valsartan’s Single-Pill Combination Therapies on Blood Pressure Control in Hypertensive Patients: Malaysian Single-Centre Real-World Experience
por: Yusof, Ahmad K. M., et al.
Publicado: (2023)

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group
por: Gupta, Vikas, et al.
Publicado: (2020)

To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease
por: Ameen,, et al.
Publicado: (2016)

Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy
por: Sultan, El-Zahraa M., et al.
Publicado: (2022)

Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review
por: Shotton, Rohan, et al.
Publicado: (2021)

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy
por: Huang, Hsin‐Ti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07jr4rv76tfkp7fs9npdcftsn4